Coen Steven P. 4

4 · Ginkgo Bioworks Holdings, Inc. · Filed Apr 20, 2026

AI-generated summary of this filing

Updated Apr 20, 2026

Ginkgo (DNA) CFO Coen S. P. Exercises RSUs, Sells Shares

What Happened

Coen Steven P., Chief Financial Officer of Ginkgo Bioworks (DNA), had restricted stock units convert to common shares and disposed of shares tied to that vesting. On 2026-04-16 he converted two derivatives (587 and 156 RSUs, total 743 RSUs) into shares. Portions of those vested shares were sold to cover tax withholding. On 2026-04-17 he sold 324 shares in an open-market transaction at $7.95 per share, receiving $2,576.

Key Details

Transaction dates and prices:
- 2026-04-16: Conversion/exercise of 587 RSUs and 156 RSUs (total 743) — exercise/conversion price not reported (derivative to common stock).
- 2026-04-16: Corresponding disposals of those derivative shares to cover tax withholding (amounts and prices for sell-to-cover not disclosed).
- 2026-04-17: Open-market sale of 324 shares at $7.95 each for $2,576.
Shares owned after the transactions: Not specified in the provided filing excerpt.
Notable footnotes:
- F1: Each RSU converts into one share of Class A common stock.
- F2: Some shares were sold to satisfy tax withholding (sell-to-cover); these are not discretionary sales.
- F3/F4: The RSUs have multi-step vesting schedules (initial vest on May 1, 2024, then monthly installments).
Filing: Report filed 2026-04-20 covering the 2026-04-16 transaction date.

Context

These transactions reflect RSU vesting and routine sell-to-cover tax withholding rather than an outright market-timed sale. The April 17 open-market sale of 324 shares is a small-dollar disposition ($2.6k) and may simply reflect liquidity needs tied to vesting rather than a broader statement of sentiment.

Form 4

Period: 2026-04-16

See remarks

Transactions

Exercise/Conversion
Class A Common Stock
[F1]
2026-04-16+587→ 50,436 total
Exercise/Conversion
Class A Common Stock
[F1]
2026-04-16+156→ 50,592 total
Sale
Class A Common Stock
[F2]
2026-04-17$7.95/sh−324$2,576→ 50,268 total
Exercise/Conversion
Restricted Stock Units
[F1][F3]
2026-04-16−587→ 7,644 total
→ Class A Common Stock (587 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2026-04-16−156→ 3,599 total
→ Class A Common Stock (156 underlying)

Footnotes (4)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
[F2]Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
[F3]The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
[F4]The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.

Signature

/s/ Karen Tepichin, Attorney-in-Fact|2026-04-20

1 file